Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1480 (LINC01480)

Target
LINC01480
Molecular classification
Other, Long non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 1480 (LINC01480) is a long non-coding RNA identified as a hub gene correlating with immune cell infiltration in coronary artery disease and ischemic cardiomyopathy. Upregulation of LINC01480 is associated with protective roles, notably promoting M2 macrophage populations, which have anti-inflammatory effects in cardiac tissues. It is also implicated in regulating immune pathways and metabolic signaling, including downregulation of the mTOR and insulin pathways, suggesting a complex role in cardiovascular and metabolic disease pathogenesis. LINC01480’s expression stratifies cardiovascular disease patients and correlates with cancer immune microenvironments, making it a candidate biomarker and potential therapeutic target. However, no direct drug interactions are documented, and further clinical and experimental validation is required before therapeutic application.

Other names
LINC01480
02

Mechanism of action

Modulates immune cell infiltration, potentially protecting against disease progression by increasing anti-inflammatory M2 macrophages. Downregulates mTOR and insulin signaling pathways, which may reduce risk of metabolic complications.

03

Biological functions

Immune cell regulation (adhesion, migration, activation)Immune cell infiltrationAnti-inflammatory function (promotes M2 macrophage polarization)Regulation of metabolic pathways (negatively regulates mTOR and insulin signaling)
04

Disease associations

Cardiovascular disease (CAD, ischemic cardiomyopathy)Cancer (endometrial cancer, lung adenocarcinoma)Type I and Type II diabetes mellitus (implied pathway involvement)
05

Safety considerations

None specifically described in current researchMajor therapeutic challenges are the lack of wet-lab validation and clinical data, making it a candidate for further investigation rather than clinical application at present
06

Biomarkers

Potential biomarker for CAD and ischemic cardiomyopathy (expression levels stratify disease patients)Upregulated in some cancers (endometrial cancer, lung adenocarcinoma)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1480 (LINC01480).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1480 (LINC01480).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call